Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Takimoto

Showing results (111-120 of 173) with videos related to

Pageof 18
Sort By:
Biochimica Et Biophysica Acta|September 29, 1999
Molecular analysis of the GCF gene identifies revisions to the cDNA and amino acid sequences(1)M Takimoto, P Mao, G Wei, et al.
Current Topics in Microbiology and Immunology|January 1, 1988
Multifactorial regulation of the human c-myc oncogeneM Zajac-Kaye, M Avigan, M Takimoto, et al.
The American Journal of Physiology|February 1, 1994
ETA and ETB receptors on single smooth muscle cells cooperate in mediating guinea pig tracheal contractionT Inui, A F James, Y Fujitani, et al.
The Journal of Biological Chemistry|May 16, 2000
Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c releaseR C Koya, H Fujita, S Shimizu, et al.
Biochemical and Biophysical Research Communications|May 6, 1996
Lack of endothelin ETB receptor binding and function in the rat with a mutant ETB receptor geneH Karaki, M Mitsui-Saito, M Takimoto, et al.
Structure (London, England : 1993)|October 15, 1993
Major antigen-induced domain rearrangements in an antibodyR L Stanfield, M Takimoto-Kamimura, J M Rini, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1984
[Adjuvant BCG immunotherapy for breast cancer (T1N0M0, T2N0M0)]T Sakurai, K Okada, H Yokoi, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 10, 1997
[Case of low-grade fibromyxoid sarcoma]Y Kataoka, M Matsuda, T Katsura, et al.
The Japanese Journal of Antibiotics|November 1, 1979
[Pharmacokinetics and clinical results of cefuroxime (CXM) (author's transl)]K Chou, M Takimoto, H Yoshioka, et al.
The Journal of Toxicological Sciences|January 19, 1999
28-day repeated oral toxicity study of a hypolipidemic agent, NK-104 in ratsT Akiba, T Shibuta, Y Amano, et al.
Pageof 18

Showing results (111-120 of 173) with videos related to

Sort By:
Pageof 18
Biochimica Et Biophysica Acta|September 29, 1999
Molecular analysis of the GCF gene identifies revisions to the cDNA and amino acid sequences(1)M Takimoto, P Mao, G Wei, et al.
Current Topics in Microbiology and Immunology|January 1, 1988
Multifactorial regulation of the human c-myc oncogeneM Zajac-Kaye, M Avigan, M Takimoto, et al.
The American Journal of Physiology|February 1, 1994
ETA and ETB receptors on single smooth muscle cells cooperate in mediating guinea pig tracheal contractionT Inui, A F James, Y Fujitani, et al.
The Journal of Biological Chemistry|May 16, 2000
Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c releaseR C Koya, H Fujita, S Shimizu, et al.
Biochemical and Biophysical Research Communications|May 6, 1996
Lack of endothelin ETB receptor binding and function in the rat with a mutant ETB receptor geneH Karaki, M Mitsui-Saito, M Takimoto, et al.
Structure (London, England : 1993)|October 15, 1993
Major antigen-induced domain rearrangements in an antibodyR L Stanfield, M Takimoto-Kamimura, J M Rini, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1984
[Adjuvant BCG immunotherapy for breast cancer (T1N0M0, T2N0M0)]T Sakurai, K Okada, H Yokoi, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 10, 1997
[Case of low-grade fibromyxoid sarcoma]Y Kataoka, M Matsuda, T Katsura, et al.
The Japanese Journal of Antibiotics|November 1, 1979
[Pharmacokinetics and clinical results of cefuroxime (CXM) (author's transl)]K Chou, M Takimoto, H Yoshioka, et al.
The Journal of Toxicological Sciences|January 19, 1999
28-day repeated oral toxicity study of a hypolipidemic agent, NK-104 in ratsT Akiba, T Shibuta, Y Amano, et al.
Pageof 18